Omnicell Inc: (NASD: OMCL)
$18.81
0.15 (0.80%)
Volume 118,422
May 17 04:00 PM ET
Zacks Rank: 2-Buy 
| #2 |
Full Company Report
Omnicell Inc., provides clinical infrastructure and workflow automation solutions that enable healthcare facilities to acquire, manage, dispense, and deliver medications and supplies more effectively and efficiently.
General Information
OMNICELL INC
590 E. MIDDLEFIELD ROAD
MOUNTAIN VIEW, CA 94043
Phone: 6502516100
Fax: 650-251-6266
Web: http://www.omnicell.com
Email: ir@omnicell.com
| Industry | MEDICAL INFO SYSTEMS |
| Sector | Medical |
| Fiscal Year End | December |
| Last Reported Quarter | 03/31/2013 |
| Next EPS Date | 08/07/2013 |
Price and Volume Information
| Zacks Rank |  |
| Yesterday's Close | 18.66 |
| 52 Week High | 20.00 |
| 52 Week Low | 12.33 |
| Beta | 1.05 |
| 20 Day Moving Average | 154,855.55 |
| Target Price Consensus | 21.50 |
% Price Change
| 4 Week | 7.24 |
| 12 Week | 3.75 |
| YTD | 25.49 |
Share Information
| Shares Outstanding (millions) | 34.10 |
| Market Capitalization (millions) | 641.40 |
| Short Ratio | 4.98 |
| Last Split Date | NA |
% Price Change Relative to S&P 500
| 4 Week | -0.85 |
| 12 Week | -6.52 |
| YTD | 8.49 |
Dividend Information
| Dividend Yield | 0.00% |
| Annual Dividend | $0.00 |
| Payout Ratio | 0.00 |
| Change in Payout Ratio | 0.00 |
| Last Dividend Payout / Amount | NA / $0.00 |
EPS Information
| Current Quarter EPS Consensus Estimate | 0.21 |
| Current Year EPS Consensus Estimate | 0.84 |
| Estimated Long-Term EPS Growth Rate | 16.70 |
| Next EPS Report Date | 08/07/2013 |
Consensus Recommendations
| Current (1=Strong Buy, 5=Strong Sell) | 1.67 |
| 30 Days Ago | 1.80 |
| 60 Days Ago | 1.80 |
| 90 Days Ago | 2.00 |
Fundamental Ratios
P/E
| Current FY Estimate | 22.39 |
| Trailing 12 Months | 30.84 |
| PEG Ratio | 1.34 |
Price Ratios
| Price/Book | 2.03 |
| Price/Cash Flow | 18.40 |
| Price / Sales | 1.90 |
Current Ratio
| 03-31-13 | 2.30 |
| 12-31-12 | 2.18 |
| 09-30-12 | 2.12 |
Net Margin
| 03-31-13 | 5.10 |
| 12-31-12 | 5.15 |
| 09-30-12 | 5.16 |
Inventory Turnover
| 03-31-13 | 6.00 |
| 12-31-12 | 6.01 |
| 09-30-12 | 5.99 |
EPS Growth
| vs. Previous Year | -23.08% |
| vs. Previous Quarter | -37.50% |
ROE
| 03-31-13 | 6.92 |
| 12-31-12 | 7.41 |
| 09-30-12 | 7.09 |
Quick Ratio
| 03-31-13 | NA |
| 12-31-12 | 1.85 |
| 09-30-12 | 1.78 |
Pre-Tax Margin
| 03-31-13 | 8.10 |
| 12-31-12 | 8.62 |
| 09-30-12 | 8.17 |
Debt-to-Equity
| 03-31-13 | 0.00 |
| 12-31-12 | 0.00 |
| 09-30-12 | 0.00 |
Sales Growth
| vs. Previous Year | 35.81% |
| vs. Previous Quarter | -3.39% |
ROA
| 03-31-13 | 4.87 |
| 12-31-12 | 5.34 |
| 09-30-12 | 5.25 |
Operating Margin
| 03-31-13 | 6.23 |
| 12-31-12 | 6.98 |
| 09-30-12 | 7.16 |
Book Value
| 03-31-13 | NA |
| 12-31-12 | 9.27 |
| 09-30-12 | 8.90 |
Debt to Capital
| 03-31-13 | NA |
| 12-31-12 | 0.00 |
| 09-30-12 | 0.00 |
